Successful Treatment of Refractory Orthostatic Intolerance (OI) With Droxidopa

Clin Pediatr (Phila). 2022 Oct;61(9):593-595. doi: 10.1177/00099228221092645. Epub 2022 Jun 8.

Authors

Christina Kokorelis^{1

2}, Joann Bodurtha², Kelsey Guthrie², Peter C Rowe²

Affiliations

¹ Kennedy Krieger Institute, Baltimore, MD, USA.
² Johns Hopkins University School of Medicine, Baltimore, MD, USA.

PMID: 35678018
DOI: 10.1177/00099228221092645

No abstract available

MeSH terms

Blood Pressure
Droxidopa* / therapeutic use
Humans
Orthostatic Intolerance* / diagnosis
Orthostatic Intolerance* / drug therapy

Substances

Droxidopa